AstraZeneca bucks layoff trend with rare disease R&D expansionR&D, TherapeuticsWhile some biopharma companies are slashing headcounts, AstraZeneca is adding 500 scientific and high-tech jobs with a significant expansion of its R&D operations in Toronto. Read more February 28, 2023/by BioSpace https://www.pharmalive.com/wp-content/uploads/2021/12/AstraZeneca-Objections-Torpedo-8-Billion-Sobi-Acquisition-BioSpace-12-3-21.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2023-02-28 10:15:232023-02-28 10:49:44AstraZeneca bucks layoff trend with rare disease R&D expansion
